"Isoantibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies from an individual that react with ISOANTIGENS of another individual of the same species.
| Descriptor ID |
D007518
|
| MeSH Number(s) |
D12.776.124.486.485.114.664 D12.776.124.790.651.114.664 D12.776.377.715.548.114.664
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Isoantibodies".
Below are MeSH descriptors whose meaning is more specific than "Isoantibodies".
This graph shows the total number of publications written about "Isoantibodies" by people in this website by year, and whether "Isoantibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 5 | 1 | 6 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 2 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 4 | 0 | 4 |
| 2018 | 2 | 0 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Isoantibodies" by people in Profiles.
-
Long-Term Outcomes of Renal Transplant Allografts With De Novo DSA in the Setting of Stable Function. Clin Transplant. 2026 May; 40(5):e70576.
-
Effectiveness of combined plasma cell therapy and costimulation blockade based desensitization regimen in heart transplant candidates. Clin Transplant. 2024 02; 38(2):e15249.
-
Long-Term Follow-Up of Renal Transplant Recipients Treated With IVIG for De Novo Donor-Specific Antibodies. Transplant Proc. 2021 Jul-Aug; 53(6):1865-1871.
-
De novo recipient-specific Glutathione S-transferase T1 antibody development after HLA-identical hematopoietic cell transplantation. Transpl Immunol. 2018 02; 46:36-41.
-
Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation. Clin Transplant. 2017 08; 31(8).
-
Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study. Transfusion. 2017 03; 57(3):525-532.
-
Can we use dilution-titration studies to identify clinically relevant HLA antibody specificities? Clin Transpl. 2013; 357-60.
-
Heart transplant graft survival is improved after a reduction in panel reactive antibody activity. J Thorac Cardiovasc Surg. 2013 Feb; 145(2):555-64; discussion 564-5.
-
Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation. Transplantation. 2012 Aug 27; 94(4):338-44.
-
An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura. J Pediatr Surg. 2012 Aug; 47(8):1537-41.